Spine Wave Revenue and Competitors

Location

$145.5M

Total Funding

Estimated Revenue & Valuation

  • Spine Wave's estimated annual revenue is currently $34.4M per year.(i)
  • Spine Wave's estimated revenue per employee is $251,000
  • Spine Wave's total funding is $145.5M.

Employee Data

  • Spine Wave has 137 Employees.(i)
  • Spine Wave grew their employee count by 0% last year.

Spine Wave's People

NameTitleEmail/Phone
1
Founder Reveal Email/Phone
2
Chief Patent CounselReveal Email/Phone
3
CFOReveal Email/Phone
4
VP - Corporate ControllerReveal Email/Phone
5
AVPReveal Email/Phone
6
VP OperationsReveal Email/Phone
7
VP, Quality & Regulatory AffairsReveal Email/Phone
8
EVP SalesReveal Email/Phone
9
Director MarketingReveal Email/Phone
10
Sr Director Marketing, Fixation & Mktg SvcsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$30.6M1224%N/AN/A
#2
$31.6M126-4%N/AN/A
#3
$17.8M710%N/AN/A
#4
$8.5M34-8%N/AN/A
#5
$5M20-31%N/AN/A
#6
$36.6M1468%N/AN/A
#7
$7.3M294%N/AN/A
#8
$6.8M270%N/AN/A
#9
$543.2M21643%N/AN/A
#10
$0.3M1-90%N/AN/A
Add Company

What Is Spine Wave?

Spine Wave was founded in February 2001 by Mark LoGuidice and John Pafford, former executives for Sofamor Danek, to commercialize the Company’s proprietary injectable spinal nucleus technology. The simultaneous Series A financing and acquisition of VERTx in 2002, a company founded and led by Tyler Lipschultz, gave Spine Wave a novel technology focused on the rapidly growing vertebral compression fracture and spinal fusion market. In February 2006, the Company closed its Series C financing, raising an additional $36.5 million, bringing the total funds raised to $90 million. Today, the Company is focused on the development and marketing of clinical solutions for large and fast growing spinal market segments. The Company’s product portfolio includes the NuCore™ Injectable Nucleus, the StaXx™ FX Fracture Repair System, the StaXx™ XD Expandable Device, and several additional products in development. Spine Wave plans to launch its first product for commercial use in late 2006.

keywords:N/A

$145.5M

Total Funding

137

Number of Employees

$34.4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Spine Wave News

2022-04-20 - Spinal Implants and Devices Market Size with Covid-19 ...

Spinal implants and devices are used to treat spinal deformities ... Axial Medical, Spine Wave, Inc., K2M, Inc., and Captiva Spine, LLC.

2022-04-20 - Scientists Unravel the Origins of the Human Spine

The segmentation clock, a set of genes that generates oscillatory waves, controls this process, with each wave giving rise to a new pair of...

2022-04-17 - Dual-Wave Spinal Cord Stimulator Delivers More Pain Relief ...

Spinal cord stimulation (SCS) therapy that delivers both paresthesia and subperception waves of stimulation appears to be more effective at providing...

2021-09-27 - Spine Wave Announces the Commercial Launch of the Salvo® 5.5/6.0mm Spine System

SHELTON, Conn., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Spine Wave is pleased to announce the successful completion of its limited market release and subsequent launch of the Salvo® 5.5/6.0mm Spine System featuring Spine Wave’s advanced modular screw design. Spine Wave launched the Salvo® 4.75mm Spin ...

2021-09-27 - Spine Wave Announces the Commercial Launch of the Salvo® 5.5/6.0mm Spine System

SHELTON, Conn., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Spine Wave is pleased to announce the successful completion of its limited market release and subsequent launch of the Salvo® 5.5/6.0mm Spine System featuring Spine Wave’s advanced modular screw design. Spine Wave launched the Salvo® 4.75mm Spin ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$39.1M14215%N/A
#2
N/A15529%N/A
#3
$37.7M16737%N/A
#4
$45.3M1680%N/A
#5
$50.2M1695%N/A